The police cybercrime unit has advised CPNI (attached) that a number of local organisations have reported recent issues with compromised email accounts resulting from users clicking on phishing emails.
The police indicate that the emails had slight variations in text, but included the line ‘The attached file is too large to be sent through pdf’ and the campaign is following familiar lines:
Email received from a compromised contact.
Link clicked prompting the user to enter their password.
Account accessed by attackers who then put in place a sweep rule to delete incoming emails (bounce backs).
Recipients contacts / inbox used as a new target list.
Contractors and their IT support will have their own internal procedures on detecting a compromised report, but the police do advise that the basic advice contained in the attached stands in that they would encourage users to report the incident, secure their account and notify any interested parties to help minimise the risk of further compromises.
ACTION
Contractors are advised to:
Inform staff of this incident and of the police cybercrime unit advice; and
Note the advice and guidance given on the CPNI website cyber security page in respect of steps you can take to protect your data and businesses.
Contractors are reminded that the storage and back up of patient sensitive data and any amendments to your systems should only be carried out in line with advice from your IT or email supplier, PMR system provider and in line with Data Protection legislation.
CPNI colleagues will continue to keep you updated on these matters.
Kind regards – Mike
SENT ON BEHALF OF PROF. MIKE MAWHINNEY Head of Regulatory Affairs
This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Colleagues,
Please find attached for your attention, correspondence from Kathryn Turner, Pharmacy Lead, HSCB.
The purpose of this correspondence is to inform community pharmacies of the following:
A change to the service specification that will allow community pharmacies to provide second doses of the AZ COVID vaccine to patients who have had their first dose administered by another provider.
Kinds regards
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Colleague
Please find correspondence HERE for your attention, from Paul Loughran, BSO Pharmaceutical Services Manager.
SUMMARY
From Thursday 1 July 2021 re-ordering of all prescription forms for use in primary care will move to an online form.
Once the online form has been completed and submitted it will automatically go to DLRT for processing and you will receive an electronic copy of the submission for your records.
Please note that this relates to ALL types of forms, including PPVs, PCD1s, and SP1/2.
ACTION
Contractors are asked to review the correspondence.
Note that from Thursday 1 July 2021 it will NOT be able to post or email a request form to DLRT.
Queries relating to the electronic form please email FPS eBusiness on ebusiness@hscni.net.
If you have any queries relating to your request for new Prescription Forms please contact DLRT on 0289 262 2999.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
Please find correspondence HERE for your attention, from HSCB Pharmacy & Medicines Management.
SUMMARY
Additional information from the Resuscitation Council was published on 4 January 2021. It states that although oxygen is advised in the recent guidance for vaccination settings, it has not been needed for routine immunisations in the community, based on a local risk assessment. The immediate availability of oxygen is not an absolute requirement for vaccination settings.
ACTION
Contractors are asked to review the correspondence.
If interested in the provision of this COVID-CPVS2, please complete the expression of interest form attached as Appendix A and return by email to local offices below by 2 July 2021.
If you have any queries please in relation to this service contact: Brendan Kerr email Brendan.kerr@hscni.net Tel: 02895363914 or Mob: 07554773972.
This Moderna EOI provides contractors with an opportunity to provide COVID vaccination services to individuals in the under 40 years of age cohort, something that is not possible with the Astra Zeneca vaccine at present.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
The following concessionary prices have been granted for June 2021:
Drug
Pack Size
Concessionary Price
Cetirizine 1mg/ml oral solution sugar free
200ml
£8.29
Donepezil 10mg orodispersible tablets sugar free
28
£83.89
Eplerenone 50mg tablets
28
£20.10
Ivabradine 5mg tablets
56
£28.88
Ivabradine 7.5mg tablets
56
£8.88
Lercanidipine 10mg tablets
28
£2.12
Lercanidipine 20mg tablets
28
£2.61
Pregabalin 100mg capsules
84
£8.47
Repaglinide 2mg tablets
90
£8.40
Sodium fluoride 0.05% mouthwash sugar free
250
£1.74
Tolbutamide 500mg tablets
28
£13.31
Trazodone 100mg capsules
56
£3.90
Trimethoprim 200mg tablets
6
£1.34
Trimethoprim 200mg tablets
14
£3.13
This is the final update of concessionary prices for June 2021.
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.